Paper39726595
A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases.
Shi L and 11 others. Front Immunol, 2024. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases. Papers, record 39726595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39726595
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A novel monoclonal antibody against human thymic stromal lymphopoietin for the treatment of TSLP-mediated diseases.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytokines | Major topic |
| Thymic Stromal Lymphopoietin | Major topic |
| Asthma | Major topic |
| Humans | |
| Animals | |
| Mice | |
| Psoriasis | |
| Antibodies, Monoclonal, Humanized | |
| Dendritic Cells | |
| Antibodies, Monoclonal | |
| Disease Models, Animal | |
| Female |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29947573 | Extending human IgG half-life using structure-guided design. | MAbs | 2018 | https://conductscience.org/library/papers/29947573 | PubMed |
| 2 | 24846652 | Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. | N Engl J Med | 2014 | https://conductscience.org/library/papers/24846652 | PubMed |
| 3 | 31723054 | TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway. | JCI Insight | 2019 | https://conductscience.org/library/papers/31723054 | PubMed |
| 4 | 31838750 | Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. | Allergy | 2020 | https://conductscience.org/library/papers/31838750 | PubMed |
| 5 | 18724870 | Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma. | Cell Commun Signal | 2008 | https://conductscience.org/library/papers/18724870 | PubMed |
| 6 | 32849527 | Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer. | Front Immunol | 2020 | https://conductscience.org/library/papers/32849527 | PubMed |
| 7 | 24573880 | TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling. | Database (Oxford) | 2014 | https://conductscience.org/library/papers/24573880 | PubMed |
| 8 | 17129180 | TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. | Annu Rev Immunol | 2007 | https://conductscience.org/library/papers/17129180 | PubMed |
| 9 | 24782181 | Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells. | Arthritis Rheumatol | 2014 | https://conductscience.org/library/papers/24782181 | PubMed |
| 10 | 33212886 | Fc-Engineering for Modulated Effector Functions-Improving Antibodies for Cancer Treatment. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/33212886 | PubMed |
| 11 | 16142237 | Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. | Nat Immunol | 2005 | https://conductscience.org/library/papers/16142237 | PubMed |
| 12 | 35685846 | Targeting TSLP in Asthma. | J Asthma Allergy | 2022 | https://conductscience.org/library/papers/35685846 | PubMed |
| 13 | 30779339 | Pharmacokinetics, Safety, and Tolerability of Tezepelumab (AMG 157) in Healthy and Atopic Dermatitis Adult Subjects. | Clin Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30779339 | PubMed |
| 14 | 27697608 | Insight into the role of TSLP in inflammatory bowel diseases. | Autoimmun Rev | 2017 | https://conductscience.org/library/papers/27697608 | PubMed |
| 15 | 31745338 | TSLP: from allergy to cancer. | Nat Immunol | 2019 | https://conductscience.org/library/papers/31745338 | PubMed |
| 16 | 17513717 | Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. | J Immunol | 2007 | https://conductscience.org/library/papers/17513717 | PubMed |
| 17 | 11711607 | Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. | J Virol | 2001 | https://conductscience.org/library/papers/11711607 | PubMed |
| 18 | 36697211 | Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. | Eur Respir Rev | 2023 | https://conductscience.org/library/papers/36697211 | PubMed |
| 19 | 18450510 | Thymic stromal lymphopoietin: a new cytokine in asthma. | Curr Opin Pharmacol | 2008 | https://conductscience.org/library/papers/18450510 | PubMed |
| 20 | 35650271 | Role of thymic stromal lymphopoietin in allergy and beyond. | Nat Rev Immunol | 2023 | https://conductscience.org/library/papers/35650271 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42110556 | Tezepelumab: redefining TSLP blockade in severe asthma through mechanistic precision and translational pharmacology. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42110556 | PubMed |
| 41904357 | Current and Emerging Biologic Therapies for Severe Asthma. | Drugs | 2026 | https://conductscience.org/library/papers/41904357 | PubMed |
| 41752128 | Mucosal Remodeling in Chronic Rhinosinusitis with Nasal Polyps: The Role of Innate Lymphoid Cells and Reprogramming Under IL-4Rα Blockade. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41752128 | PubMed |
| 41409758 | Potential of alarmin-targeted bispecific and combination therapies in airway disease. | Front Allergy | 2025 | https://conductscience.org/library/papers/41409758 | PubMed |
| 41294800 | A Bispecific Antibody Blocking Both TSLP and IL-4Rα for the Treatment of Allergic Inflammatory Diseases. | Cells | 2025 | https://conductscience.org/library/papers/41294800 | PubMed |
| 40909165 | Advances of bispecific antibodies using/application in dermatology: a review. | Front Allergy | 2025 | https://conductscience.org/library/papers/40909165 | PubMed |
| 40283665 | Challenges and Opportunities in Achieving Asthma Remission. | J Clin Med | 2025 | https://conductscience.org/library/papers/40283665 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C1QA | 712 | PubTator's text mining | https://conductscience.org/library/genes/712 | NCBI Gene |
| CCL17 | 6361 | PubTator's text mining | https://conductscience.org/library/genes/6361 | NCBI Gene |
| CD1C | 911 | PubTator's text mining | https://conductscience.org/library/genes/911 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| STAT5A | 6776 | PubTator's text mining | https://conductscience.org/library/genes/6776 | NCBI Gene |
| TSLP | 85480 | PubTator's text mining | https://conductscience.org/library/genes/85480 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39726595
GET https://conductscience.org/api/papers/v1/39726595/references?page=2